Insights
Report Library
Browse our full archive of reports. Filter by health area, disease or condition, product, and date. Written by our expert analysts, our reports highlight key messages in the data, make the case for change and offer actionable recommendations.
-404x404.webp)
15 min read
100 Days Mission: 5th Implementation Report and Scorecard
The 100 Days Mission's 5th Implementation Report and Scorecard highlight limited progress has been made in an R&D ecosystem that remains reactive and reliant on US funding.
10 min read
The Ripple Effect 2.0: from global health to domestic value
This executive briefing highlights findings from three case studies: the Shingrix shingles vaccine, the JADA System for postpartum haemorrhage and BCG as a treatment for bladder cancer. It provides quantitative, country-specific proof points showing how these selected global health innovations improve health outcomes and deliver economic value across the US, UK, Japan and Europe.
5 min read
From malaria research to protecting aging populations: AS01 Adjuvant in Shingrix
This case study focuses on the benefits of AS01 adjuvant, initially advanced through malaria research, before being adopted to enhance the effectiveness of GSK’s ‘Shingrix’ shingles vaccine.
5 min read
From targeted solution to global maternal health asset: the JADA System
This case study focuses on the benefits of the JADA System – a device designed to stop bleeding by inducing a gentle vacuum in the uterus uterine device – for the rapid control of PPH in the USA.
5 min read
From TB prevention to cancer: the BCG vaccine treating bladder cancer
This case study focuses on the benefits of the BCG vaccine, originally developed from preventing tuberculosis (TB), which is now used as an alternative to chemotherapy in the treatment of bladder cancers in high income countries.
20 min read
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research stage, and sector.
30 min read
The ripple effect: how global health R&D delivers for everyone
This report shows how investments in global health R&D deliver significant health and economic progress for HICs as well as LMICs. We examine how much government funding from HICs has gone to global health R&D, how much of it stays within HICs, and the macroeconomic and scientific gains it leads to. We spotlight case studies that show how innovations developed for LMICs have gone on to help HIC populations, proving that smart, sustained investment pays dividends globally and locally.
20 min read
Flying Blind
This report provides a critical and timely landscape analysis of global R&D for endometriosis, polycystic ovary syndrome (PCOS) and uterine fibroids. In it, we evaluate and contextualise current investment, and review and analyse the pipeline of biomedical products developed and used to diagnose and treat them.
20 min read
Irresistible: developing new solutions for antimicrobial resistant STIs
In this report, we consider the future global response to three AMR-risk STIs: gonorrhoea, trichomoniasis and Mycoplasma genitalium. We analyse the funding that has been provided to research and develop new treatments, vaccines and diagnostics, and the resulting product pipeline for each of the three infections and their disease-causing pathogens.
You may also be interested in
Hubs
Your destination for a curated collection of data, insights and tools on the most pressing global health topics. Explore our hubs on Women’s Health, the Impact of Global Health R&D, and more to launch in the future.
Health Areas
Our Health Areas resource gives you an at-a-glance summary of the state of innovation and annual R&D investment by disease and condition. Updated regularly, this is a unique quick reference for the global health community.